by Integumen_1 | May 28, 2019 | Labskin, Labskin AI, StoerForMen, Updates
Three new Labskin AI contracts, including CBD infused tampons to relieve period cramp Integumen today announces that Labskin AI, the virtual laboratory platform, has entered into testing agreements with three new clients – a leading chain drug store, a European...
by Integumen_1 | May 21, 2019 | Financials, Investors, Labskin, StoerForMen, Updates
Trading update – board changes Trading Update Integumen announces the resignation of Tony Richardson as Chairman and a director of the Company and Ross Andrews has been appointed as Chairman, with immediate effect. The Company expects to announce an additional...
by Integumen_1 | May 12, 2019 | Labskin, Labskin AI, Updates
Launch of Labskin human skin clone tests for Medical Device and Clinical Research trials Integumen today announces the roll-out of the Labskin human clone skin testing platform into the medical device and clinical research sectors. Combined with human volunteers...
by Integumen_1 | May 2, 2019 | Financials, Labskin, Labskin AI, StoerForMen, Updates
Appointment of Fionán Murray, as Group Sales Director Fionán Murray has joined Integumen as Group Sales Director, and as a Director of the Company with a focus on extending digital services on top of existing Labskin physical services to rapidly grow the Labskin AI...
by Integumen_1 | Apr 25, 2019 | Financials, Investors, Labskin, Labskin AI, StoerForMen, Updates
Turner Pope Investor Evening Integumen is pleased to announce that Gerry Brandon, the Company’s CEO, will be presenting at an investor evening hosted by Turner Pope Investments (TPI) Ltd, on Monday 13th May 2019. The event will be held in London, EC2 and will...
by Integumen_1 | Apr 25, 2019 | Labskin, StoerForMen, Updates
Labskin STOER study demonstrates 54% increase in skin hydration in 24 hours Promotion of new skin cells leaving fresher looking skin Launch of New Animal-Free Labskin Dandruff Test Integumen today announces the completion of development and launch of a new...
Recent Comments